Arthritis

New stem cell clinic ‘National Institutes for Regenerative Medicine’ has NIH-like name, cites UCSD affiliation

National-IRM

Some American stem cell clinics that operate without FDA approval can give the appearance of being in the mainstream of academic stem cell research. Sometimes they go a step further to hint at or even say that they have some kind of federal approval as we saw in the past with the Stem.md website. Why …

New stem cell clinic ‘National Institutes for Regenerative Medicine’ has NIH-like name, cites UCSD affiliation Read More »

Weekend Reads: Cool Papers, PubPeer, Jacob Hanna, & More

journals1

Here are some papers and news for weekend reads. What are you reading this weekend? What are your go-to stem cell journals? Hostile Takeover: Glioma Stem Cells Recruit TAMs to Support Tumor Progression by Yu Shi, Yi-fang Ping, Xia Zhang, Xiu-wu Bian in Cell Stem Cell. YAP1 Regulates OCT4 Activity and SOX2 Expression to Facilitate self-renewal and …

Weekend Reads: Cool Papers, PubPeer, Jacob Hanna, & More Read More »

Arthritis Foundation Sell Out To Stem Cell Clinic Celltex?

Celltex-Arthritis

The Texas stem cell clinic Celltex was one of the most controversial businesses in the world of stem cells in 2012 and 2013 (see here for background and as an update see this new post on how the Texas clinic has teamed up with a local university). The FDA essentially shut down the Celltex clinical …

Arthritis Foundation Sell Out To Stem Cell Clinic Celltex? Read More »

Emergency Suspension of Stem Cell Clinic Doc Kenneth Welker

Oregon-Optimal-Health

The Oregon State Medical Board took emergency action to suspend the medical license of Dr. Kenneth Welker of Eugene, Oregon on Thursday. Update: Unfortunately, the Associate Press (AP) story on this topic (discussed more below) contains numerous important mistakes including thoroughly mixing up embryonic, adult, and induced pluripotent stem cells (iPSC). Keep that in mind. Also, sadly …

Emergency Suspension of Stem Cell Clinic Doc Kenneth Welker Read More »

Book Excerpt: Stem Cells for Alzheimer’s Disease–Are We There yet?

Below is an excerpt focused on Alzheimer’s Disease from my new book on stem cells. Stem Cells: An Insider’s Guide, which is targeted to a broad audience of people interested in stem cells. Alzheimer’s Disease (AD) is one of the most devastating illnesses. It destroys the brain, which shrinks over time (see image from Wikipedia …

Book Excerpt: Stem Cells for Alzheimer’s Disease–Are We There yet? Read More »

Interview with Dr. Steven Victor of IntelliCell Biosciences (SVFC)

Steven-Victor-250x3001

What’s the deal with IntelliCell Biosciences, headed up by Dr. Steven Victor? Sometimes science can move at warp speed and that is even more true of the stem cell field. One stem cell establishment that seems to be in a particularly intense period of activity and that has drawn a great deal of attention lately …

Interview with Dr. Steven Victor of IntelliCell Biosciences (SVFC) Read More »

A-Rod BioGenesis Performance Enhancing Drug Use & Stem Cell Therapies

250px-Alex_Rodriguez_2008-04-19-194x3001

Baseball’s superstar A-Rod reportedly is deeply ensnared in a scandal involving a  small-time anti-aging clinic in Florida, Biogenesis, which helped numerous MLB players dope. Anti-aging is big business. Some anti-aging clinics push performance enhancing drugs (PEDs), while a growing number of others pitch stem cells. Many sell both. Star athletes are flocking to unproven stem …

A-Rod BioGenesis Performance Enhancing Drug Use & Stem Cell Therapies Read More »

Stem Cells An Insider’s Guide: More on My New Book

In about a month my new book, Stem Cells: An Insider’s Guide, should be available as an e-book from the publisher and from Amazon. It’s available for pre-order now at Amazon here. The “real” book (i.e. the one made of paper) should be available in September. The book costs $29. Any writers out there interested in doing …

Stem Cells An Insider’s Guide: More on My New Book Read More »

Short-term safety of lab-grown stem cells for arthritis: encouraging, but key caveats

A new paper suggests a hopeful short-term safety profile of laboratory-grown stem cells for treatment of arthritis, but there are some important limitations to the study too. A debate continues to bubble over whether to classify laboratory-propagated stem cells as biological drugs. A persistent issue has been whether the growth of stem cells in culture …

Short-term safety of lab-grown stem cells for arthritis: encouraging, but key caveats Read More »